With your own knowledge and the help of the following document:

Document 1 (Title: Recurrent Rectal Cancer Management Following Primary Radiotherapy): Pelvic exenteration represents a potentially curative option for selected patients with recurrent rectal cancer, though previous treatments may influence subsequent surgical outcomes. Multivariate analysis of prognostic factors reveals that primary tumor radiotherapy history significantly impacts post-exenteration prognosis through several documented mechanisms. Retrospective review of 182 patients undergoing pelvic exenteration for recurrent disease demonstrated that prior radiotherapy was independently associated with reduced 5-year survival (hazard ratio 1.78, 95% CI 1.26-2.47) after controlling for other established prognostic variables. Histopathological analysis of exenteration specimens revealed that previously irradiated tumors demonstrated altered recurrence patterns, with increased likelihood of multifocal pelvic disease and perineural invasion compared to radiation-naïve recurrences. Intraoperative assessment consistently documented increased technical difficulty achieving clear margins in previously irradiated fields, with complete resection rates of 72% versus 89% in non-irradiated cases. Additionally, postoperative complication profiles showed significant differences, with prior radiotherapy associated with doubled rates of major wound complications and anastomotic failures. Tissue analysis demonstrated radiation-induced fibrosis and microvascular changes that appear to both complicate surgical procedures and potentially provide microenvironmental conditions favoring aggressive tumor biology. These findings remain significant in multivariate modeling accounting for radiation timing, dose, and fractionation schedules. Notably, neoadjuvant radiotherapy for the primary tumor demonstrated stronger negative prognostic impact than adjuvant approaches. These relationships have important implications for primary rectal cancer management decisions, as treatment approaches potentially influence salvage options for future recurrences. Emerging evidence suggests that alternative primary management strategies preserving radiation as a salvage option may warrant consideration in selected cases after accounting for these documented prognostic relationships.
Document 2 (Title: Management Approaches for Colorectal Cancer with Synchronous Hepatic Metastases): Colorectal cancer with synchronous liver metastases presents complex management challenges requiring multidisciplinary coordination across surgical oncology, medical oncology, radiation oncology, and interventional specialties. Various institutional models have emerged with claims regarding centralized versus distributed care advantages. Comparative outcomes analysis between management approaches demonstrates that organizational structure itself appears less influential than process-specific quality metrics. A multicenter registry study examining 1,842 patients treated for synchronous disease found no statistically significant differences in overall survival (38.6 vs 39.2 months, p=0.82) or progression-free survival between patients managed at unified centers versus coordinated multi-facility care when controlling for treatment sequence, surgical approach, and chemotherapy protocols. Implementation of standardized multidisciplinary treatment protocols achieved equivalent outcomes regardless of care setting centralization. Treatment sequencing decisions, surgical quality metrics, and appropriate interdisciplinary coordination demonstrated substantially stronger outcome associations than facility organizational structure. Detailed process analysis revealed that adherence to evidence-based protocols, rather than care setting, determined outcome quality, with protocol compliance explaining 42% of outcome variation compared to 3% explained by centralization status. Notably, patient-reported experience measures demonstrated no significant differences in coordination perception between unified and distributed models employing virtual tumor boards and standardized communication pathways. Logistical advantages of centralized care appeared offset by potential disadvantages in geographical access and treatment delays for many patients. These findings contradict assumptions that centralized facilities inherently provide superior outcomes, instead highlighting the importance of process standardization, communication infrastructure, and protocol adherence regardless of organizational structure. Contemporary management increasingly emphasizes these quality determinants rather than specific facility models.
Document 3 (Title: Predictive Modeling in Prostate Cancer Management): Biochemical recurrence (BCR) has served as a standard endpoint in prostate cancer research, with numerous predictive nomograms developed to forecast PSA-based recurrence. However, the clinical relevance of BCR as a surrogate for more meaningful patient outcomes remains an important question for predictive tool evaluation. Comparative analysis of existing nomograms designed for BCR prediction demonstrates their capabilities extend to more clinically significant endpoints. Validation studies examining 3,428 patients across multiple institutions found that BCR-focused prediction tools successfully predicted metastasis-free survival with concordance indices of 0.77-0.82 in independent datasets. Additionally, these same models demonstrated strong predictive capacity for prostate cancer-specific mortality despite being calibrated for biochemical endpoints. Multi-institutional registry data confirms that high-performing BCR nomograms maintain discriminatory accuracy when applied to hard clinical endpoints including metastasis development, treatment escalation requirements, and disease-specific survival. This predictive consistency likely reflects the underlying biological relationships between disease characteristics and progressive disease behavior captured in well-designed models. Comparative assessment between biochemical and clinical endpoint prediction shows that while recalibration improves absolute accuracy, the relative discriminatory performance remains largely intact across endpoint types. These findings suggest that well-validated BCR nomograms provide valuable clinical information beyond biochemical recurrence risk alone and can appropriately inform treatment decision-making regarding more meaningful patient outcomes.

Answer the following true/false question.
Question: Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
Options:
A. True
B. False

Please respond **only** with a single valid JSON object in the following format:
{"answer": "True"}  ← if the answer is true
{"answer": "False"} ← if the answer is false
Do not include any other text or comments. Output must be strictly JSON.